Concepedia

Guillermo Peluffo

GP

Statistics

Publications

13

Citations

1.8K

H-Index

12

Active since

2004

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

Universidad de Buenos Aires

Harvard Stem Cell Institute

Brigham and Women's Hospital

Guillermo Peluffo is an author at Dana-Farber Cancer Institute specializing in oncology, medicine, and molecular oncology.

ORCID

Publications per year

2004–2023

13

Publications

13

Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer

Shaokun Shu, Charles Y. Lin, Housheng Hansen He et al. · Nature · 2016 · 629 citations · Full text

, , +14

KDM5 Histone Demethylase Activity Links Cellular Transcriptomic Heterogeneity to Therapeutic Resistance

Kunihiko Hinohara, Hua‐Jun Wu, Sébastien Vigneau et al. · Cancer Cell · 2018 · 254 citations · Full text

, , +12

JARID1B Is a Luminal Lineage-Driving Oncogene in Breast Cancer

Zhenhua Wu, Hege G. Russnes, Shinji Takagi et al. · Cancer Cell · 2014 · 208 citations · Full text

, , +11

Role of COX-2 in epithelial–stromal cell interactions and progression of ductal carcinoma in situ of the breast

Min Hu, Guillermo Peluffo, Haiyan Chen et al. · Proceedings of the National Academy of Sciences · 2009 · 202 citations · Full text

, , +17

JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States

Laura E. Stevens, Guillermo Peluffo, Xintao Qiu et al. · Cancer Research · 2022 · 101 citations · Full text

, , +17

1–5 of 13